Drofenine hydrochloride is a synthetic derivative of phenylacetic acid classified as an anticonvulsant agent that functions as a potent competitive inhibitor of butyrylcholinesterase. Used primarily in… Read more
Drofenine hydrochloride is a synthetic derivative of phenylacetic acid classified as an anticonvulsant agent that functions as a potent competitive inhibitor of butyrylcholinesterase. Used primarily in the treatment of epilepsy and related seizure disorders, this compound requires rigorous analytical oversight during pharmaceutical development. The Drofenine hydrochloride category includes high-quality reference standards, such as the N-oxide metabolite and stable isotope labelled compounds like deuterated isotopologues. These reference materials are essential tools for pharmaceutical laboratories performing critical tasks such as impurity profiling, method validation, and ongoing quality control. By providing access to precise impurity standards and labelled analogs, these products enable researchers to accurately monitor potential degradation pathways and ensure regulatory compliance during the synthesis and formulation of the drug.